Injective (INJ) is currently trading at $3.58, experiencing a minor decline of 1.61% over the past 24 hours. The price has fluctuated between a high of $3.65 and a low of $3.48, indicating a daily range of 0.17%, reflecting stable short-term price action.

The trading volume stands at approximately $47 million, corresponding to a volume-to-market cap ratio of 13.15%, suggesting decent liquidity in the market. The short-term moving averages are mixed, with the 8 SMA and 13 SMA showing upward momentum, while the 55 SMA indicates a potential resistance level around $3.63.

The 1-hour RSI at 46 indicates that INJ is nearing neutral territory, suggesting a lack of immediate buying pressure. However, the 7-day RSI at 55 indicates a bullish sentiment, as the price has appreciated over the last week by 9.37% and shows a stronger performance of 19.99% over the past two weeks.

Over a longer timeframe, INJ has appreciated by 27.07% in the last 30 days, signaling robust bullish momentum. Despite its proximity to the all-time high of $52.62 reached in March 2024, current price action suggests a significant retracement, which could provide a buying opportunity for traders seeking to capitalize on potential recovery.

In summary, while there is a slight short-term bearish sentiment reflected in the 24-hour price change, the longer-term indicators and RSI suggest that INJ may be poised for a rebound. Given the current technical setup and volume dynamics, a Buy rating is warranted, as the price appears to be establishing a base for potential upward movement.